James Clinton's Biography

James Clinton, Senior Scientist, American Type Culture Collection (ATCC)

James Clinton is a Senior Scientist and group leader in Research & Development at ATCC. His team is working on the development and commercialization of advanced, physiologically relevant in vitro models utilizing primary and induced pluripotent stem cells, as well as exploring recently emerging culture techniques such as 3D organoids and co-culture approaches.

Next-Generation Organoid Cancer Models from the Human Cancer Models Initiative

Monday, 14 October 2019 at 14:00

Add to Calendar ▼2019-10-14 14:00:002019-10-14 15:00:00Europe/LondonNext-Generation Organoid Cancer Models from the Human Cancer Models InitiativeStem Cells in Drug Discovery Tox and Organoids 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

ATCC is manufacturing and distributing models from The Human Cancer Models Initiative, an international consortium dedicated to generating hundreds of novel primary patient-derived cancer models, including three-dimensional organoids. These models can be propagated from cryopreserved material and are annotated with clinical and molecular data. HCMI models are intended as pre-clinical tools for disease modeling, biomarker identification, compound screening, and personalized medicine. These models hold promise to transform cancer research by being more physiologically relevant and predictive than existing in vitro models. In this presentation I provide an overview of the HCMI and ATCC’s involvement in making these novel cancer models available to the research community.

Add to Calendar ▼2019-10-14 00:00:002019-10-15 00:00:00Europe/LondonStem Cells in Drug Discovery Tox and Organoids 2019Stem Cells in Drug Discovery Tox and Organoids 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors